Crysvita®

Crysvita® (Burosumab-twza) is the only FDA-approved medicine for adults and children 6 months of age and older with X-linked hypophosphatemia (XLH). CRYSVITA works by targeting the underlying cause of this progressive and lifelong disease.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.